Illinois General Assembly - Bill Status for HB5373
Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

 Bill Status of HB5373  103rd General Assembly


House Sponsors
Rep. Kelly M. Cassidy - Sonya M. Harper, Barbara Hernandez and Hoan Huynh

Senate Sponsors
(Sen. Laura Fine)

Last Action
DateChamber Action
  4/19/2024SenateReferred to Assignments

Statutes Amended In Order of Appearance
720 ILCS 570/315.7 new
720 ILCS 570/318

Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Provides that decisions regarding the treatment of patients experiencing chronic pain shall be made by the prescriber with dispensing by the pharmacist in accordance with the corresponding responsibility as described in federal regulations and State administrative rules. Provides that ordering, prescribing, dispensing, administering, or paying for controlled substances, including opioids, shall not be predetermined by specific morphine milligram equivalent guidelines. Provides that confidential information received from opioid treatment programs or confidential information otherwise protected under federal confidentiality of substance use disorder patient records shall not be included in the information shared to the central repository under the Prescription Monitoring Program. Provides that an applicant for this information must have a valid court order or subpoena for the confidential information requested. Defines "chronic pain" and "opiates". Effective immediately.

House Committee Amendment No. 1
Defines "chronic pain" as pain that persists for more than 12 weeks and is adversely affecting the function or well-being of the individual (rather than just pain that persists for more than 12 weeks).

House Floor Amendment No. 2
Provides that nothing in concerning chronic pain treatment shall interfere with the review of prescriptions by the Prescription Monitoring Program's Advisory Committee. Provides that in reviewing prescriptions for chronic pain, the advisory committee members shall review the most updated clinical guidelines on treating chronic pain for the period the prescriptions were written. Provides that upon review and approval by a licensed prescriber or dispenser, the Prescription Monitoring Program administrator or the Department of Human Service's general legal counsel may release information under the Prescription Monitoring Program that would otherwise be confidential.

DateChamber Action
  2/9/2024HouseFiled with the Clerk by Rep. Kelly M. Cassidy
  2/9/2024HouseFirst Reading
  2/9/2024HouseReferred to Rules Committee
  2/28/2024HouseAssigned to Human Services Committee
  3/7/2024HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Kelly M. Cassidy
  3/7/2024HouseHouse Committee Amendment No. 1 Referred to Rules Committee
  3/8/2024HouseTo Revenue - Property Tax Subcommittee
  3/12/2024HouseHouse Committee Amendment No. 1 Rules Refers to Human Services Committee
  3/13/2024HouseAdded Co-Sponsor Rep. Barbara Hernandez
  3/21/2024HouseHouse Committee Amendment No. 1 Adopted in Human Services Committee; by Voice Vote
  3/21/2024HouseDo Pass as Amended / Short Debate Human Services Committee; 009-000-000
  3/21/2024HousePlaced on Calendar 2nd Reading - Short Debate
  4/15/2024HouseHouse Floor Amendment No. 2 Filed with Clerk by Rep. Kelly M. Cassidy
  4/15/2024HouseHouse Floor Amendment No. 2 Referred to Rules Committee
  4/16/2024HouseHouse Floor Amendment No. 2 Rules Refers to Human Services Committee
  4/17/2024HouseHouse Floor Amendment No. 2 Recommends Be Adopted Human Services Committee; 009-000-000
  4/17/2024HouseSecond Reading - Short Debate
  4/17/2024HouseHeld on Calendar Order of Second Reading - Short Debate
  4/18/2024HouseAdded Co-Sponsor Rep. Hoan Huynh
  4/18/2024HouseAdded Chief Co-Sponsor Rep. Sonya M. Harper
  4/18/2024HouseHouse Floor Amendment No. 2 Adopted
  4/18/2024HousePlaced on Calendar Order of 3rd Reading - Short Debate
  4/18/2024HouseThird Reading - Short Debate - Passed 105-000-000
  4/19/2024SenateArrive in Senate
  4/19/2024SenatePlaced on Calendar Order of First Reading
  4/19/2024SenateChief Senate Sponsor Sen. Laura Fine
  4/19/2024SenateFirst Reading
  4/19/2024SenateReferred to Assignments

Back To Top